Guidelines for the management of adult lower respiratory tract infections--full version (Q28249185)

1

0 references

F Blasi

2

0 references

S Ewig

3

0 references

J Garau

4

0 references

G Huchon

5

0 references

M Ieven

6

0 references

A Ortqvist

7

0 references

T Schaberg

8

0 references

A Torres

9

0 references

G van der Heijden

10

0 references

R Read

11

0 references

T J M Verheij

Clinical Microbiology and Infection

12

0 references

language of work or name

English

0 references

publication date

November 2011

0 references

published in

0 references

volume

17 Suppl 6

0 references

page(s)

E1-59

0 references

cites work

Health care-associated pneumonia and community-acquired pneumonia: a single-center experience

1 reference

12 December 2020

Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa

1 reference

12 December 2020

Prospective study of the aetiology and outcome of pneumonia in the community

1 reference

12 December 2020

An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus

1 reference

12 December 2020

Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia

1 reference

12 December 2020

Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service

1 reference

12 December 2020

Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak

1 reference

12 December 2020

Community-acquired pneumonia in the intensive care unit: epidemiological and prognosis data in older people

1 reference

12 December 2020

Vaccines for preventing influenza in the elderly

1 reference

12 December 2020

Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?

1 reference

12 December 2020

Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan

1 reference

12 December 2020

Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?

1 reference

12 December 2020

Inpatient computer-based standing orders vs physician reminders to increase influenza and pneumococcal vaccination rates: a randomized trial

1 reference

12 December 2020

Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD.

1 reference

12 December 2020

Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae.

1 reference

12 December 2020

A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit

1 reference

12 December 2020

Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity

1 reference

12 December 2020

Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study

1 reference

12 December 2020

Near-patient assays for diagnosis of influenza virus infection in adult patients

1 reference

12 December 2020

Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study

1 reference

12 December 2020

Pharmacokinetics-pharmacodynamics of quinolones against Streptococcus pneumoniae in patients with community-acquired pneumonia

1 reference

12 December 2020

Health care-associated Staphylococcus aureus pneumonia

1 reference

12 December 2020

Community-acquired pneumonia in the elderly: Spanish multicentre study.

1 reference

12 December 2020

Viral and mycoplasmal pneumonia in a prepaid medical care group during an eight-year period

1 reference

12 December 2020

Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐Resistant Streptococcus pneumoniae

1 reference

12 December 2020

Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group

1 reference

12 December 2020

Examining the evidence for the use of vitamin C in the prophylaxis and treatment of the common cold

1 reference

12 December 2020

Microbiology of Severe Aspiration Pneumonia in Institutionalized Elderly

1 reference

12 December 2020

Community-acquired pneumonia in Shanghai, China: microbial etiology and implications for empirical therapy in a prospective study of 389 patients

1 reference

12 December 2020

Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.

1 reference

12 December 2020

Aetiology of, and risk factors for, recurrent community-acquired pneumonia

1 reference

12 December 2020

Evaluation of polymerase chain reaction and culture for diagnosis of pertussis in the control of a county-wide outbreak focused among adolescents and adults

1 reference

12 December 2020

The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004

1 reference

12 December 2020

Etiology of community-acquired pneumonia treated in an ambulatory setting

1 reference

12 December 2020

Etiology of community-acquired pneumonia in patients requiring hospitalization

1 reference

12 December 2020

Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia

1 reference

12 December 2020

Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: pleiotropic benefits or residual confounding?

1 reference

12 December 2020

Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review

1 reference

12 December 2020

Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates

1 reference

12 December 2020

The diagnostic value of history and physical examination for COPD in suspected or known cases: a systematic review

1 reference

12 December 2020

Early mobilization of patients hospitalized with community-acquired pneumonia

1 reference

12 December 2020

Severe respiratory disease concurrent with the circulation of H1N1 influenza.

1 reference

12 December 2020

The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy

1 reference

12 December 2020

Role of infection in chronic bronchitis

1 reference

12 December 2020

Viral lower respiratory tract infection in the elderly: a prospective in-hospital study.

1 reference

12 December 2020

Delayed administration of antibiotics and mortality in patients with community-acquired pneumonia.

1 reference

12 December 2020

Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial

1 reference

12 December 2020

Severe community-acquired pneumonia. Etiology, prognosis, and treatment

1 reference

12 December 2020

Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults

1 reference

12 December 2020

Clinical experience with levofloxacin in the treatment of pneumonia in ICU patients.

1 reference

12 December 2020

Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan.

1 reference

12 December 2020

Serological evidence of Mycoplasma pneumoniae infection in acute exacerbation of COPD.

1 reference

12 December 2020

Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.

1 reference

12 December 2020

Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush

1 reference

12 December 2020

Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia

1 reference

12 December 2020

Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae

1 reference

12 December 2020

Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors

1 reference

12 December 2020

Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia

1 reference

12 December 2020

Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland

1 reference

12 December 2020

Increased detection of respiratory syncytial virus, influenza viruses, parainfluenza viruses, and adenoviruses with real-time PCR in samples from patients with respiratory symptoms.

1 reference

12 December 2020

A VIROLOGIC STUDY OF CHRONIC BRONCHITIS.

1 reference

12 December 2020

Clinical efficacy of anti-pneumococcal vaccination in patients with COPD.

1 reference

12 December 2020

Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis

1 reference

12 December 2020

Efficacy of COLD-fX in the prevention of respiratory symptoms in community-dwelling adults: a randomized, double-blinded, placebo controlled trial

1 reference

12 December 2020

Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia

1 reference

12 December 2020

Fluoroquinolones vs macrolides in the treatment of Legionnaires disease.

1 reference

12 December 2020

Macrolide resistance in bacteremic pneumococcal disease: implications for patient management.

1 reference

12 December 2020

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.

1 reference

12 December 2020

Etiologic study of patients with community-acquired pneumonia

1 reference

12 December 2020

Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough

1 reference

12 December 2020

Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality

1 reference

12 December 2020

The value of the lipid-laden macrophage index in the assessment of aspiration pneumonia

1 reference

12 December 2020

Infections with viruses, Mycoplasma pneumoniae and bacteria in acute respiratory illness. A study of hospitalized patients, patients treated at home, and healthy subjects

1 reference

12 December 2020

Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens

1 reference

12 December 2020

Comparison of the sensitivity of the Legionella urinary antigen EIA kits from Binax and Biotest with urine from patients with infections caused by less common serogroups and subgroups of Legionella

1 reference

12 December 2020

Early diagnosis of congestive heart failure: clinical utility of B-type natriuretic peptide testing associated with Doppler echocardiography.

1 reference

12 December 2020

Community-acquired aspiration pneumonia in intensive care units. Epidemiological and prognosis data.

1 reference

12 December 2020

In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas

1 reference

12 December 2020

C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia

1 reference

12 December 2020

The role of corticosteroids in severe community-acquired pneumonia: a systematic review

1 reference

12 December 2020

Chlamydophila pneumoniae diagnostics: importance of methodology in relation to timing of sampling

1 reference

12 December 2020

Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone

1 reference

12 December 2020

Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors

1 reference

12 December 2020

Reporting hospitals' antibiotic timing in pneumonia: adverse consequences for patients?

1 reference

12 December 2020

Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum

1 reference

12 December 2020

Prospective study of epidemiology and prognostic factors in community-acquired pneumonia

1 reference

12 December 2020

Influenza vaccination for healthcare workers who work with the elderly

1 reference

12 December 2020

Assessment of a commercial rapid urinary antigen test to detect Streptococcus pneumoniae in patients who received 23-valent pneumococcal polysaccharide vaccine

1 reference

12 December 2020

Efficacy of fluticasone on cough: a randomised controlled trial

1 reference

12 December 2020

Metronidazole vs clindamycin treatment of anerobic pulmonary infection. Failure of metronidazole therapy.

1 reference

12 December 2020

Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia

1 reference

12 December 2020

Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia

1 reference

12 December 2020

In-hospital observation after antibiotic switch in pneumonia: a national evaluation

1 reference

12 December 2020

Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia

1 reference

12 December 2020

An open-label, randomized comparison of levofloxacin and amoxicillin/clavulanate plus clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia.

1 reference

12 December 2020

Chlamydia pneumoniae, Strain TWAR, Infection in Patients with Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia.

1 reference

12 December 2020

The 23-Valent Pneumococcal Polysaccharide Vaccine. Part II. A Cost-Effectiveness Analysis for Invasive Disease in the Elderly in England and Wales

1 reference

12 December 2020

Cost-effectiveness of full-course oral levofloxacin in severe community-acquired pneumonia

1 reference

12 December 2020

Tigecycline versus levofloxacin for the treatment of community-acquired pneumonia: European experience

1 reference

12 December 2020

Predicting death in elderly patients with community-acquired pneumonia: a prospective validation study reevaluating the CRB-65 severity assessment tool

1 reference

12 December 2020

Pneumococcal pneumonia in the UK--how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV)

1 reference

12 December 2020

Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response

1 reference

12 December 2020

Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia.

1 reference

12 December 2020

Severity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people?

1 reference

12 December 2020

Over-the-counter (OTC) medications for acute cough in children and adults in ambulatory settings

1 reference

12 December 2020

Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.

1 reference

12 December 2020

CRB-65 predicts death from community-acquired pneumonia.

1 reference

12 December 2020

Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule

1 reference

12 December 2020

Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel

1 reference

12 December 2020

Prolonged antibiotics for purulent bronchiectasis

1 reference

12 December 2020

Levofloxacin efficacy in the treatment of community-acquired legionellosis

1 reference

12 December 2020

Community-acquired pneumonia in southeast Asia: the microbial differences between ambulatory and hospitalized patients

1 reference

12 December 2020

Predicting the need for mechanical ventilation and/or inotropic support for young adults admitted to the hospital with community-acquired pneumonia

1 reference

12 December 2020

Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease

1 reference

12 December 2020

Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season

1 reference

12 December 2020

Aetiology and outcome of severe community-acquired pneumonia.

1 reference

12 December 2020

Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome

1 reference

12 December 2020

Streptococcus pneumoniae DNA load in blood as a marker of infection in patients with community-acquired pneumonia

1 reference

12 December 2020

Microbial airway colonization is associated with noninvasive ventilation failure in exacerbation of chronic obstructive pulmonary disease.

1 reference

12 December 2020

The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults

1 reference

12 December 2020

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

1 reference

12 December 2020

Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis.

1 reference

12 December 2020

Aetiology of community-acquired pneumonia in hospital treated patients

1 reference

12 December 2020

Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia

1 reference

12 December 2020

Microbiological Testing and Outcome of Patients With Severe Community-Acquired Pneumonia

1 reference

12 December 2020

A prediction model for bacterial etiology in acute exacerbations of COPD.

1 reference

12 December 2020

A systematic review of the preventive effect of oral hygiene on pneumonia and respiratory tract infection in elderly people in hospitals and nursing homes: effect estimates and methodological quality of randomized controlled trials

1 reference

12 December 2020

The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia

1 reference

12 December 2020

Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization

1 reference

12 December 2020

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

1 reference

12 December 2020

Causes of pneumonia presenting to a district general hospital

1 reference

12 December 2020

Antivirals for influenza in healthy adults: systematic review.

1 reference

12 December 2020

Non-response to specific serotypes likely cause for failure to 23-valent pneumococcal polysaccharide vaccine in the elderly

1 reference

12 December 2020

Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern Mediterranean region

1 reference

12 December 2020

Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma.

1 reference

12 December 2020

Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis

1 reference

12 December 2020

Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia

1 reference

12 December 2020

Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community

1 reference

12 December 2020

Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission--a randomized trial.

1 reference

12 December 2020

Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease

1 reference

12 December 2020

Occurrence and treatment of suspected pneumonia in long-term care residents dying with advanced dementia

1 reference

12 December 2020

C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia--influence of antibiotic pre-treatment: results from the German competence network CAPNETZ.

1 reference

12 December 2020

Mortality of COPD Patients Infected with Multi-Resistant Pseudomonas aeruginosa: A Case and Control Study

1 reference

12 December 2020

The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease.

1 reference

12 December 2020

Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study

1 reference

12 December 2020

Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia

1 reference

12 December 2020

Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection

1 reference

12 December 2020

Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods.

1 reference

12 December 2020

Fluoroquinolone treatment of community-acquired pneumonia: a meta-analysis

1 reference

12 December 2020

Revaccination of adults with spinal cord injury using the 23-valent pneumococcal polysaccharide vaccine

1 reference

12 December 2020

Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients

1 reference

12 December 2020

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

1 reference

12 December 2020

Evaluation of the Oxoid Xpect Legionella test kit for detection of Legionella pneumophila serogroup 1 antigen in urine

1 reference

12 December 2020

Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors

1 reference

12 December 2020

Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis

1 reference

12 December 2020

Staphylococcus aureus in community-acquired pneumonia

1 reference

12 December 2020

Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia

1 reference

12 December 2020

Diagnosis of Streptococcus pneumoniae infections in adults with bacteremia and community-acquired pneumonia: clinical comparison of pneumococcal PCR and urinary antigen detection

1 reference

12 December 2020

Detection of Mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology.

1 reference

12 December 2020

Repeated pneumonia severity index measurement after admission increases its predictive value for mortality in severe community-acquired pneumonia

1 reference

12 December 2020

Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community

1 reference

12 December 2020

Neurohormonal activation and diagnostic value of cardiac peptides in patients with suspected mild heart failure

1 reference

12 December 2020

Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia

1 reference

12 December 2020

Adrenal response in severe community-acquired pneumonia: impact on outcomes and disease severity

1 reference

12 December 2020

Etiology of severe pneumonia in the very elderly

1 reference

12 December 2020

Viral community-acquired pneumonia in nonimmunocompromised adults

1 reference

12 December 2020

Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial.

1 reference

12 December 2020

Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis

1 reference

12 December 2020

Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment

1 reference

12 December 2020

Full-course oral levofloxacin for treatment of hospitalized patients with community-acquired pneumonia

1 reference

12 December 2020

Usefulness of real-time PCR for lytA, ply, and Spn9802 on plasma samples for the diagnosis of pneumococcal pneumonia

1 reference

12 December 2020

Acute infections of the chest in general practice.

1 reference

12 December 2020

Infective agents and chronic bronchitis

1 reference

12 December 2020

Severe community acquired pneumonia: a one-year analysis in a tertiary referral intensive care unit.

1 reference

12 December 2020

Impact of atypical coverage for patients with community-acquired pneumonia managed on the medical ward: results from the United States Community-Acquired Pneumonia Project.

1 reference

12 December 2020

Statins for the prevention and treatment of infections: a systematic review and meta-analysis

1 reference

12 December 2020

The efficacy of high-dose penicillin for community-acquired pneumonia diagnosed by pneumococcal urine antigen test

1 reference

12 December 2020

Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia

1 reference

12 December 2020

Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks.

1 reference

12 December 2020

Comparison of three Legionella urinary antigen assays during an outbreak of legionellosis in Belgium.

1 reference

12 December 2020

Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations

1 reference

12 December 2020

Conventional Influenza Vaccination Is Not Associated with Complications in Working-Age Patients with Asthma or Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Factors associated with the hospitalization of low-risk patients with community-acquired pneumonia in a cluster-randomized trial

1 reference

12 December 2020

Comparison of oral ciprofloxacin and amoxycillin in treating infective exacerbations of bronchiectasis in Hong Kong

1 reference

12 December 2020

Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis.

1 reference

12 December 2020

Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus

1 reference

12 December 2020

Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy

1 reference

12 December 2020

Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis

1 reference

12 December 2020

A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.

1 reference

12 December 2020

The outcome of community acquired pneumonia treated on the intensive care unit

1 reference

12 December 2020

A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia

1 reference

12 December 2020

Azithromycin in the Treatment of Legionella Pneumonia Requiring Hospitalization

1 reference

12 December 2020

Severe Community-acquired Pneumonia: Epidemiology and Prognostic Factors

1 reference

12 December 2020

Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit

1 reference

12 December 2020

Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community

1 reference

12 December 2020

Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain

1 reference

12 December 2020

Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan

1 reference

12 December 2020

Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin

1 reference

12 December 2020

Procalcitonin and severity of community-acquired pneumonia

1 reference

12 December 2020

Adjunctive therapies for community-acquired pneumonia: a systematic review

1 reference

12 December 2020

Factors associated with unknown aetiology in patients with community-acquired pneumonia.

1 reference

12 December 2020

Health Care–Associated Pneumonia Requiring Hospital Admission

1 reference

12 December 2020

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

12 December 2020

Pneumonia--a clinical or radiographic diagnosis? Etiology and clinical features of lower respiratory tract infection in adults in general practice

1 reference

12 December 2020

Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis

1 reference

12 December 2020

The Effect of Pseudomonas aeruginosa Infection on Clinical Parameters in Steady-State Bronchiectasis

1 reference

12 December 2020

Project protect: pneumococcal vaccination in Washington State nursing homes.

1 reference

12 December 2020

Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece

1 reference

12 December 2020

Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock*

1 reference

12 December 2020

Statins and the risk of pneumonia: a population-based, nested case-control study

1 reference

12 December 2020

Clinical response to ertapenem in severe community-acquired pneumonia: a retrospective series in an elderly population.

1 reference

12 December 2020

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

1 reference

12 December 2020

The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.

1 reference

12 December 2020

Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course

1 reference

12 December 2020

Comparative efficacy of inactivated and live attenuated influenza vaccines

1 reference

12 December 2020

Usefulness of pneumococcal antigen detection in pleural fluid samples by immunochromatographic assay for diagnosis of pneumococcal pneumonia

1 reference

12 December 2020

Microbial pathogens of adult community-acquired pneumonia in Southern Estonia

1 reference

12 December 2020

Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial

1 reference

12 December 2020

Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia

1 reference

12 December 2020

Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study

1 reference

12 December 2020

Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection

1 reference

12 December 2020

Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity

1 reference

12 December 2020

Statin use and risk of community acquired pneumonia in older people: population based case-control study

1 reference

12 December 2020

Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: benefit due to influenza and pneumococcal vaccination not demonstrated

1 reference

12 December 2020

A multiple-center survey on the use in clinical practice of noninvasive ventilation as a first-line intervention for acute respiratory distress syndrome*

1 reference

12 December 2020

Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia

1 reference

12 December 2020

Diagnostic yield of quantitative endotracheal aspirates in patients with severe nursing home-acquired pneumonia

1 reference

12 December 2020

C-reactive protein is an independent predictor of severity in community-acquired pneumonia

1 reference

12 December 2020

Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.

1 reference

12 December 2020

Quantitative real-time PCR tests for diagnostic and prognostic purposes in cases of legionellosis.

1 reference

12 December 2020

Declining length of hospital stay for pneumonia and postdischarge outcomes.

1 reference

12 December 2020

A diagnostic rule for the aetiology of lower respiratory tract infections as guidance for antimicrobial treatment

1 reference

12 December 2020

Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease

1 reference

12 December 2020

Sputum gram stain assessment in community-acquired bacteremic pneumonia.

1 reference

12 December 2020

Major chest infection managed at home

1 reference

12 December 2020

Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].

1 reference

12 December 2020

Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia

1 reference

12 December 2020

Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital

1 reference

12 December 2020

Can history and exam alone reliably predict pneumonia?

1 reference

12 December 2020

Clinical judgment versus the Pneumonia Severity Index in making the admission decision

1 reference

12 December 2020

Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumonia.

1 reference

12 December 2020

Emergence in france of multiple clones of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin

1 reference

12 December 2020

Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia

1 reference

12 December 2020

Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study

1 reference

12 December 2020

Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir

1 reference

12 December 2020

Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia

1 reference

12 December 2020

A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia

1 reference

12 December 2020

Markers of treatment failure in hospitalised community acquired pneumonia

1 reference

12 December 2020

Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation

1 reference

12 December 2020

Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort

1 reference

12 December 2020

The development of pharmacokinetically enhanced amoxicillin/clavulanate for the management of respiratory tract infections in adults

1 reference

12 December 2020

Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial.

1 reference

12 December 2020

Vitamin C for preventing and treating the common cold

1 reference

12 December 2020

Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial

1 reference

12 December 2020

Non-invasive ventilation in do-not-intubate patients: five-year follow-up on a two-year prospective, consecutive cohort study

1 reference

12 December 2020

Vaccines for preventing pneumococcal infection in adults

1 reference

12 December 2020

Detection of Legionella antigen in nonconcentrated and concentrated urine samples by a new immunochromatographic assay

1 reference

12 December 2020

Predominance of staphylococcal cassette chromosome mec (SCCmec) type IV among methicillin-resistant Staphylococcus aureus (MRSA) in a Swedish county and presence of unknown SCCmec types with Panton-Valentine leukocidin genes

1 reference

12 December 2020

A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission

1 reference

12 December 2020

Association between timing of intensive care unit admission and outcomes for emergency department patients with community-acquired pneumonia

1 reference

12 December 2020

Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis

1 reference

12 December 2020

Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia

1 reference

12 December 2020

Relationship Between Bacterial Flora in Sputum and Functional Impairment in Patients With Acute Exacerbations of COPD

1 reference

12 December 2020

Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapy

1 reference

12 December 2020

Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care

1 reference

12 December 2020

Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations

1 reference

12 December 2020

Prevalence and clinical significance of fever in acute exacerbations of chronic obstructive pulmonary disease

1 reference

12 December 2020

Human disease from influenza A (H5N1), Thailand, 2004.

1 reference

12 December 2020

Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience

1 reference

12 December 2020

Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes

1 reference

12 December 2020

Comparison of usefulness of plasma procalcitonin and C-reactive protein measurements for estimation of severity in adults with community-acquired pneumonia

1 reference

12 December 2020

The incidence of legionella pneumonia: a 1-year prospective study in a large community hospital.

1 reference

12 December 2020

Severity assessment of lower respiratory tract infection in elderly patients in primary care

1 reference

12 December 2020

Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens

1 reference

12 December 2020

Community-acquired pneumonia in adults: a multicentric observational AIPO study.

1 reference

12 December 2020

New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality

1 reference

12 December 2020

Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro

1 reference

12 December 2020

Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia

1 reference

12 December 2020

Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes

1 reference

12 December 2020

Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures

1 reference

12 December 2020

Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation

1 reference

12 December 2020

Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease.

1 reference

12 December 2020

Rapid detection of pneumococcal antigen in serum samples for diagnosing pneumococcal pneumonia

1 reference

12 December 2020

Significance of Aspergillus fumigatus isolation from respiratory specimens of nongranulocytopenic patients.

1 reference

12 December 2020

Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis.

1 reference

12 December 2020

Time for first antibiotic dose is not predictive for the early clinical failure of moderate-severe community-acquired pneumonia

1 reference

12 December 2020

Chlamydia species as a cause of community-acquired pneumonia in Canada

1 reference

12 December 2020

Acute respiratory failure in patients with severe community-acquired pneumonia. A prospective randomized evaluation of noninvasive ventilation

1 reference

12 December 2020

Population Snapshot of EmergentStreptococcus pneumoniaeSerotype 19A in the United States, 2005

1 reference

12 December 2020

Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults

1 reference

12 December 2020

Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae

1 reference

12 December 2020

Severity of pneumococcal pneumonia associated with genomic bacterial load.

1 reference

12 December 2020

Community-acquired pneumonia. Importance of initial noninvasive bacteriologic and radiographic investigations

1 reference

12 December 2020

National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study

1 reference

12 December 2020

Virological studies in chronic bronchitis

1 reference

12 December 2020

Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.

1 reference

12 December 2020

Respiratory viral infection in exacerbations of COPD.

1 reference

12 December 2020

Community-acquired pneumonia: is there difference in etiology between hospitalized and out-patients?

1 reference

12 December 2020

Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function

1 reference

12 December 2020

Vaccines for preventing pneumococcal infection in adults

1 reference

12 December 2020

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory

1 reference

12 December 2020

Utility of real-time PCR for diagnosis of Legionnaires' disease in routine clinical practice

1 reference

12 December 2020

Guidelines for the management of adult lower respiratory tract infections

1 reference

12 December 2020

Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatme

1 reference

12 December 2020

Impact of the Legionella urinary antigen test on epidemiological trends in community outbreaks of legionellosis in Catalonia, Spain, 1990–2004

1 reference

12 December 2020

Evidence of bias in estimates of influenza vaccine effectiveness in seniors

1 reference

12 December 2020

Corticosteroid treatment of severe community-acquired pneumonia

1 reference

12 December 2020

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

1 reference

12 December 2020

Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia

1 reference

12 December 2020

Incidence and characteristics of viral community-acquired pneumonia in adults.

1 reference

12 December 2020

Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

1 reference

12 December 2020

Community-acquired pneumonia requiring hospitalization: 5-year prospective study

1 reference

12 December 2020

Patient reminder and recall systems to improve immunization rates

1 reference

12 December 2020

Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity

1 reference

12 December 2020

Clindamycin vs penicillin for anaerobic lung infections. High rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus.

1 reference

12 December 2020

Epidemiology of community-acquired pneumonia in adults: a population-based study

1 reference

12 December 2020

Assessment of the Usefulness of Sputum Culture for Diagnosis of Community-Acquired Pneumonia Using the PORT Predictive Scoring System

1 reference

12 December 2020

A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia

1 reference

12 December 2020

Bacterial infection and risk factors in outpatients with acute exacerbation of chronic obstructive pulmonary disease: a 2-year prospective study

1 reference

12 December 2020

Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis

1 reference

12 December 2020

A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD.

1 reference

12 December 2020

Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin

1 reference

12 December 2020

In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas

1 reference

12 December 2020

New strains of bacteria and exacerbations of chronic obstructive pulmonary disease

1 reference

12 December 2020

Respiratory viral infections in hospital patients with chronic bronchitis. Observations during periods of exacerbation and quiescence

1 reference

12 December 2020

Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor

1 reference

12 December 2020

Relation of sputum colour to bacterial load in acute exacerbations of COPD

1 reference

12 December 2020

Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care

1 reference

12 December 2020

Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines

1 reference

12 December 2020

Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.

1 reference

12 December 2020

Respiratory syncytial virus infection in adults

1 reference

12 December 2020

Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study

1 reference

12 December 2020

Pneumonia versus aspiration pneumonitis in nursing home residents: diagnosis and management

1 reference

12 December 2020

The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis

1 reference

12 December 2020

Selective use of blood cultures in emergency department pneumonia patients

1 reference

12 December 2020

The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. The British Thoracic Society Research Committee and The Public Health Laboratory Service

1 reference

12 December 2020

The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumonia

1 reference

12 December 2020

Microbiologic follow-up study in adult bronchiectasis

1 reference

12 December 2020

Evaluation of an algorithm for switching from IV to PO therapy in clinical practice in patients with community-acquired pneumonia

1 reference

12 December 2020

Admission D-dimer can identify low-risk patients with community-acquired pneumonia.

1 reference

12 December 2020

Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis

1 reference

12 December 2020

A new diagnostic approach to the patient with severe pneumonia

1 reference

12 December 2020

Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease

1 reference

12 December 2020

Performance measures, vaccinations, and pneumonia rates among high-risk patients in Veterans Administration health care

1 reference

12 December 2020

Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults.

1 reference

12 December 2020

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes

1 reference

12 December 2020

Macrolide and ketolide resistance with Streptococcus pneumoniae

1 reference

12 December 2020

Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease

1 reference

12 December 2020

Prospective study of community-acquired pneumonia of bacterial etiology in adults

1 reference

12 December 2020

Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia

1 reference

12 December 2020

Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbead-based assay

1 reference

12 December 2020

Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.

1 reference

12 December 2020

Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ.

1 reference

12 December 2020

Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong

1 reference

12 December 2020

Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients

1 reference

12 December 2020

A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD.

1 reference

12 December 2020

SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia

1 reference

12 December 2020

A case series of macrolide treatment failures in community acquired pneumonia

1 reference

12 December 2020

Sensitivity of urinary antigen test in relation to clinical severity in a large outbreak of Legionella pneumonia in Spain

1 reference

12 December 2020

Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess

1 reference

12 December 2020

Risk of aspiration pneumonia after an epileptic seizure: a retrospective analysis of 1634 adult patients

1 reference

12 December 2020

Influenza vaccination for healthcare workers who work with the elderly

1 reference

12 December 2020

Free and Total Cortisol Levels as Predictors of Severity and Outcome in Community-acquired Pneumonia

1 reference

12 December 2020

Role of bacteria in acute exacerbations of chronic obstructive pulmonary disease

1 reference

12 December 2020

Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease.

1 reference

12 December 2020

Differences in Etiology of Pneumonias in Nursing Home and Community Patients

1 reference

12 December 2020

The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis

1 reference

12 December 2020

Utility of a pneumonia severity index in the optimization of the diagnostic and therapeutic effort for community-acquired pneumonia

1 reference

12 December 2020

New evidence of risk factors for community-acquired pneumonia: a population-based study.

1 reference

12 December 2020

The role of viruses in the aetiology of community-acquired pneumonia in adults.

1 reference

12 December 2020

Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

Emerging pathogens of community-acquired pneumonia: a two-year prospective study.

1 reference

12 December 2020

Sample type is crucial to the diagnosis of Mycoplasma pneumoniae pneumonia by PCR.

1 reference

12 December 2020

C-reactive protein and community-acquired pneumonia in ambulatory care: systematic review of diagnostic accuracy studies

1 reference

12 December 2020

Antibiotics for bacteremic pneumonia: Improved outcomes with macrolides but not fluoroquinolones

1 reference

12 December 2020

Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain.

1 reference

12 December 2020

Bacterial infection in exacerbated COPD with changes in sputum characteristics

1 reference

12 December 2020

Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response

1 reference

12 December 2020

Prevalence of legionellosis among adults: a study of community-acquired pneumonia in France

1 reference

12 December 2020

Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia

1 reference

12 December 2020

Clinical characteristics at initial presentation and impact of dual therapy on the outcome of bacteremic Streptococcus pneumoniae pneumonia in adults

1 reference

12 December 2020

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

1 reference

12 December 2020

Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999-2007.

1 reference

12 December 2020

Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study

1 reference

12 December 2020

Detection of Haemophilus influenzae in respiratory secretions from pneumonia patients by quantitative real-time polymerase chain reaction.

1 reference

12 December 2020

Viral and Mycoplasma pneumoniae infections in exacerbations of chronic lung disease.

1 reference

12 December 2020

In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery.

1 reference

12 December 2020

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

12 December 2020

Etiology and therapy of community-acquired pneumonia

1 reference

12 December 2020

Differences in the features of aspiration pneumonia according to site of acquisition: community or continuing care facility

1 reference

12 December 2020

Community-acquired bacteraemic pneumococcal pneumonia in adults: effect of diminished penicillin susceptibility on clinical outcome.

1 reference

12 December 2020

Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review.

1 reference

12 December 2020

An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting

1 reference

12 December 2020

A comparison of nursing home-acquired pneumonia patients with patients with community-acquired pneumonia and nursing home patients without pneumonia

1 reference

12 December 2020

Mixed community-acquired pneumonia in hospitalised patients

1 reference

12 December 2020

Analysis of factors that contribute to treatment failure in patients with community-acquired pneumonia

1 reference

12 December 2020

Prophylactic antibiotic therapy for chronic bronchitis.

1 reference

12 December 2020

A prediction rule for elderly primary-care patients with lower respiratory tract infections

1 reference

12 December 2020

Efficacy and safety of sequential amoxicillin-clavulanate in the treatment of anaerobic lung infections

1 reference

12 December 2020

Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia

1 reference

12 December 2020

Influenza vaccination among college and university students: impact on influenzalike illness, health care use, and impaired school performance

1 reference

12 December 2020

Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults

1 reference

12 December 2020

Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations

1 reference

12 December 2020

High incidence of aspiration pneumonia in community- and hospital-acquired pneumonia in hospitalized patients: a multicenter, prospective study in Japan

1 reference

12 December 2020

Etiology of community-acquired pneumonia in out-patients

1 reference

12 December 2020

Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course

1 reference

12 December 2020

Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area

1 reference

12 December 2020

Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis

1 reference

12 December 2020

Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection

1 reference

12 December 2020

Community-acquired pneumonia: new facets of an old disease--Hantavirus pulmonary syndrome

1 reference

12 December 2020

Indicators of bacterial infection in patients with acute exacerbation of chronic bronchitis for application in clinical trials of antibacterial drugs

1 reference

12 December 2020

Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007.

1 reference

12 December 2020

Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia

1 reference

12 December 2020

Validation of urinary antigen test for Streptococcus pneumoniae in patients with pneumococcal pneumonia

1 reference

12 December 2020

Effectiveness of pneumococcal polysaccharide vaccine in older adults

1 reference

12 December 2020

Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.

1 reference

12 December 2020

Treatment of aspiration pneumonia and primary lung abscess. Penicillin G vs clindamycin

1 reference

12 December 2020

Erythromycin resistance by ribosome modification

1 reference

12 December 2020

Hospital study of adult community-acquired pneumonia

1 reference

12 December 2020

Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection

1 reference

12 December 2020

Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study.

1 reference

12 December 2020

Antibiotic use, hospital admissions, and mortality before and after implementing guidelines for nursing home-acquired pneumonia

1 reference

12 December 2020

Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study

1 reference

12 December 2020

Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study

1 reference

12 December 2020

Antibiotics for community acquired pneumonia in adult outpatients

1 reference

12 December 2020

Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain.

1 reference

12 December 2020

Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial

1 reference

12 December 2020

Pseudomonas aeruginosa in chronic obstructive pulmonary disease.

1 reference

12 December 2020

Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.

1 reference

12 December 2020

Recurrence of pneumonia in middle-aged and elderly adults after hospital-treated pneumonia: aetiology and predisposing conditions.

1 reference

12 December 2020

Comparison and evaluation of four commercial kits relative to an in-house immunofluorescence test for detection of antibodies against Legionella pneumophila.

1 reference

12 December 2020

Adult community-acquired pneumonia in central London

1 reference

12 December 2020

Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

1 reference

12 December 2020

A prospective study of the diagnostic utility of sputum Gram stain in pneumonia

1 reference

12 December 2020

The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials

1 reference

12 December 2020

Mixed microbial aetiology of community-acquired pneumonia in children

1 reference

12 December 2020

Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study

1 reference

12 December 2020

Validation of a predictive rule for the management of community-acquired pneumonia

1 reference

12 December 2020

Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia

1 reference

12 December 2020

Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia

1 reference

12 December 2020

Antimicrobial susceptibilities of 930 Haemophilus influenzae clinical strains isolated from the island of Crete, Greece

1 reference

12 December 2020

Comparison and evaluation of real-time PCR, real-time nucleic acid sequence-based amplification, conventional PCR, and serology for diagnosis of Mycoplasma pneumoniae

1 reference

12 December 2020

Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies

1 reference

12 December 2020

Evaluation of the Binax NOW Streptococcus pneumoniae urinary antigen assay in intensive care patients hospitalized for pneumonia.

1 reference

12 December 2020

Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia

1 reference

12 December 2020

Mycoplasma pneumoniae and its role as a human pathogen

1 reference

12 December 2020

Prophylaxis for acute exacerbations of chronic bronchitis using an antibacterial sublingual vaccine obtained through mechanical lysis: a clinical and pharmacoeconomic study

1 reference

12 December 2020

Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.

1 reference

12 December 2020

Chlamydia pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease: analysis of 250 hospitalizations

1 reference

12 December 2020

Treating patients not diagnoses: challenging assumptions underlying the investigation and management of LRTI in general practice.

1 reference

12 December 2020

Staphylococcus aureus pneumonia: emergence of MRSA in the community

1 reference

12 December 2020

Prognostic factors for serious morbidity and mortality from community-acquired lower respiratory tract infections among the elderly in primary care.

1 reference

12 December 2020

The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency Medicine

1 reference

12 December 2020

An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome

1 reference

12 December 2020

Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study

1 reference

12 December 2020

Comparison of diagnostic sensitivities of three assays (Bartels enzyme immunoassay [EIA], Biotest EIA, and Binax NOW immunochromatographic test) for detection of Legionella pneumophila serogroup 1 antigen in urine.

1 reference

12 December 2020

Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis

1 reference

12 December 2020

Prospective study on the etiology of community-acquired pneumonia in children and adults in Spain

1 reference

12 December 2020

Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia

1 reference

12 December 2020

Comparison of two urinary antigen tests for establishment of pneumococcal etiology of adult community-acquired pneumonia

1 reference

12 December 2020

The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens

1 reference

12 December 2020

Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients

1 reference

12 December 2020

Etiology of community-acquired pneumonia. Evaluation by transtracheal aspiration, blood culture, or serology.

1 reference

12 December 2020

Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia

1 reference

12 December 2020

Microbial aetiology of community-acquired pneumonia in hospitalised patients

1 reference

12 December 2020

Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia.

1 reference

12 December 2020

Aetiological role of viral and bacterial infections in acute adult lower respiratory tract infection (LRTI) in primary care

1 reference

12 December 2020

Impact of management guidelines on the outcome of severe community acquired pneumonia

1 reference

12 December 2020

Pneumonic vs nonpneumonic acute exacerbations of COPD.

1 reference

12 December 2020

Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia

1 reference

12 December 2020

Avian influenza A (H5N1) infection in humans

1 reference

12 December 2020

Blood cultures for community-acquired pneumonia: are they worthy of two quality measures? A systematic review

1 reference

12 December 2020

Impaired pneumococcal antibody response in bronchiectasis of unknown aetiology.

1 reference

12 December 2020

Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia

1 reference

12 December 2020

Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group

1 reference

12 December 2020

Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

1 reference

12 December 2020

The bacteriology of pneumonia diagnosed in Western Australian emergency departments

1 reference

12 December 2020

Evaluating the use of a Streptococcus pneumoniae urinary antigen detection kit for the management of community-acquired pneumonia in Japan

1 reference

12 December 2020

Sputum specimens can be obtained from patients with community-acquired pneumonia in primary care

1 reference

12 December 2020

Comparison of first-line with second-line antibiotics for acute exacerbations of chronic bronchitis: a metaanalysis of randomized controlled trials

1 reference

12 December 2020

Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory tract infections and from bacteraemias in the UK and Ireland, 1999 to 2007.

1 reference

12 December 2020

Infections with Viruses and Mycoplasma pneumoniae during Exacerbations of Chronic Bronchitis

1 reference

12 December 2020

Admission is not always necessary for patients with community-acquired pneumonia in risk classes IV and V diagnosed in the emergency room

1 reference

12 December 2020

Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation

1 reference

12 December 2020

Process of care performance, patient characteristics, and outcomes in elderly patients hospitalized with community-acquired or nursing home-acquired pneumonia.

1 reference

12 December 2020

Prior statin use is associated with improved outcomes in community-acquired pneumonia

1 reference

12 December 2020

Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009.

1 reference

12 December 2020

Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden

1 reference

12 December 2020

Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain

1 reference

12 December 2020

Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia

1 reference

12 December 2020

Identification of 90% of patients ultimately diagnosed with community-acquired pneumonia within four hours of emergency department arrival may not be feasible

1 reference

12 December 2020

A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiology.

1 reference

12 December 2020

Drug‐Resistant Pneumococcal Pneumonia: Clinical Relevance and Related Factors

1 reference

12 December 2020

Budesonide and the risk of pneumonia: a meta-analysis of individual patient data

1 reference

12 December 2020

Oral health and mortality risk from pneumonia in the elderly

1 reference

12 December 2020

Contribution of a pleural antigen assay (Binax NOW) to the diagnosis of pneumococcal pneumonia

1 reference

12 December 2020

Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors

1 reference

12 December 2020

Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients

1 reference

12 December 2020

Legionella: an infrequent cause of adult community acquired pneumonia in Dublin

1 reference

12 December 2020

Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection.

1 reference

12 December 2020

The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses.

1 reference

12 December 2020

Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland

1 reference

12 December 2020

Sputum examination in the clinical management of community-acquired pneumonia

1 reference

12 December 2020

Prognostic Factors of Pneumonia Requiring Admission to the Intensive Care Unit

1 reference

12 December 2020

Aetiology and clinical presentation of mild community-acquired bacterial pneumonia.

1 reference

12 December 2020

Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia.

1 reference

12 December 2020

Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials

1 reference

12 December 2020

Treatment of penicillin-resistant pneumococcal bacteremia in neutropenic patients with cancer.

1 reference

12 December 2020

Additive preventive effect of influenza and pneumococcal vaccines in elderly persons

1 reference

12 December 2020

Early evolution of arterial oxygenation in severe community-acquired pneumonia: a prospective observational study

1 reference

12 December 2020

Review of pneumococcal conjugate vaccine in adults: implications on clinical development

1 reference

12 December 2020

Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study

1 reference

12 December 2020

Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae

1 reference

12 December 2020

Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease.

1 reference

12 December 2020

Treatment of the common cold with unrefined echinacea. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ).

1 reference

12 December 2020

Atypical pathogens as etiologic agents in hospitalized patients with community-acquired pneumonia in Korea: a prospective multi-center study

1 reference

12 December 2020

Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy

1 reference

12 December 2020

Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine

1 reference

12 December 2020

Treatment and outcomes for patients with bacteremic pneumococcal pneumonia

1 reference

12 December 2020

Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia

1 reference

12 December 2020

Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

1 reference

12 December 2020

Antibiotics for acute bronchitis

1 reference

12 December 2020

Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study

1 reference

12 December 2020

Vaccines for preventing influenza in healthy adults

1 reference

12 December 2020

Analysis of eight commercial enzyme immunoassay tests for detection of antibodies to Mycoplasma pneumoniae in human serum

1 reference

12 December 2020

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia

1 reference

12 December 2020

A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae

1 reference

12 December 2020

Protective Effects of the 23‐Valent Pneumococcal Polysaccharide Vaccine in the Elderly Population: The EVAN‐65 Study

1 reference

12 December 2020

Respiratory syncytial virus outbreak in a long-term care facility detected using reverse transcriptase polymerase chain reaction: an argument for real-time detection methods

1 reference

12 December 2020

Validation of the 2001 American Thoracic Society criteria for severe community-acquired pneumonia.

1 reference

12 December 2020

A Three-year Study of Severe Community-acquired Pneumonia With Emphasis on Outcome

1 reference

12 December 2020

Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.

1 reference

12 December 2020

Penicillin-binding proteins and cell shape in E. coli

1 reference

12 December 2020

Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess

1 reference

12 December 2020

Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease

1 reference

12 December 2020

Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital

1 reference

12 December 2020

Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany

1 reference

12 December 2020

Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis

1 reference

12 December 2020

Antibiotics for exacerbations of chronic obstructive pulmonary disease

1 reference

12 December 2020

Chlamydia pneumoniae infection and acute exacerbation of chronic obstructive pulmonary disease (COPD).

1 reference

12 December 2020

Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard".

1 reference

12 December 2020

Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong

1 reference

12 December 2020

Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study.

1 reference

12 December 2020

Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia

1 reference

12 December 2020

Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients

1 reference

12 December 2020

Modification of the risk of mortality from pneumonia with oral hygiene care

1 reference

12 December 2020

Implication of clinical pathway care for community-acquired pneumonia in a community hospital: early switch from an intravenous beta-lactam plus a macrolide to an oral respiratory fluoroquinolone

1 reference

12 December 2020

Persistence of Streptococcus pneumoniae urinary antigen excretion after pneumococcal pneumonia

1 reference

12 December 2020

Validation of predictive rules and indices of severity for community acquired pneumonia

1 reference

12 December 2020

Severe Community-Acquired Pneumonia

1 reference

12 December 2020

Microbiologic Determinants of Exacerbation in Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Low prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae among patients with symptoms of respiratory tract infections in Dutch general practices

1 reference

12 December 2020

Diagnosis of invasive pneumococcal infection by serotype-specific urinary antigen detection

1 reference

12 December 2020

Legionella pneumophila

1 reference

12 December 2020

Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.

1 reference

12 December 2020

Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness

1 reference

12 December 2020

Diagnosis of atypical pathogens in patients hospitalized with community-acquired respiratory infection

1 reference

12 December 2020